Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0341-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0340-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0339-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0338-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0337-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0336-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0335-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0334-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0333-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0332-2023Class IITerminatedMar 1, 2023TIROSINT - SOLSubpotent DrugIbsa Pharma Inc · D-0331-2023Class IIOngoingMar 1, 2023Tacrolimus CapsulesPresence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.Dr. Reddy's Laboratories, Inc. · D-0330-2023Class IIITerminatedMar 1, 2023Dermoplast FIRST AID ANTIBACTERIAL SPRAYSubpotent Drug: Low assay observed in one of the two active ingredients during stability testing.Advantice Health, Llc · D-0329-2023Class IITerminatedFeb 22, 2023BuPROPion Hydrochloride TabletsFailed Impurities/Degradation SpecificationsAmerisource Health Services LLC · D-0328-2023Class IITerminatedFeb 22, 2023AbelcetLack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.Leadiant Biosciences, Inc. · D-0327-2023Class IIOngoingFeb 22, 2023Humatrix Microclysmic GelCGMP Deviations: initiated due to violations of CGMP manufacturing practicesConsolidated Chemical, Inc · D-0326-2023Class IIOngoingFeb 22, 2023Techni-Care Chloroxylenold 3%CGMP Deviations: initiated due to violations of CGMP manufacturing practicesConsolidated Chemical, Inc · D-0325-2023Class IITerminatedFeb 22, 2023VITAMIN KLack of sterility assuranceSentara Infusion Services · D-0324-2023Class IITerminatedFeb 22, 2023VANCOMYCINLack of sterility assuranceSentara Infusion Services · D-0323-2023Class IITerminatedFeb 22, 2023VancomycinLack of sterility assuranceSentara Infusion Services · D-0322-2023Class IITerminatedFeb 22, 2023TPN (a) 95GM/AALack of sterility assuranceSentara Infusion Services · D-0321-2023Class IITerminatedFeb 22, 2023TPN (a) 115GM/AALack of sterility assuranceSentara Infusion Services · D-0320-2023Class IITerminatedFeb 22, 2023TPN 107gm/AALack of sterility assuranceSentara Infusion Services · D-0319-2023Class IITerminatedFeb 22, 2023TPN (a) 100GM/AALack of sterility assuranceSentara Infusion Services · D-0318-2023Class IITerminatedFeb 22, 2023TOBRAMYCIN 660MG IN NS 66MLLack of sterility assuranceSentara Infusion Services · D-0317-2023Class IITerminatedFeb 22, 2023Sodium Chloride 0.9 %Lack of sterility assuranceSentara Infusion Services · D-0316-2023Class IITerminatedFeb 22, 2023PIPERACILLIN / TAZOBACTAMLack of sterility assuranceSentara Infusion Services · D-0315-2023Class IITerminatedFeb 22, 2023PENICILLINLack of sterility assuranceSentara Infusion Services · D-0314-2023Class IITerminatedFeb 22, 2023PANTOPRAZOLE 30MG IN NS 7.5MLLack of sterility assuranceSentara Infusion Services · D-0313-2023Class IITerminatedFeb 22, 2023ONDANSETRON 8MG IN NS 100MLLack of sterility assuranceSentara Infusion Services · D-0312-2023Class IITerminatedFeb 22, 2023NALBUPHINELack of sterility assuranceSentara Infusion Services · D-0311-2023Class IITerminatedFeb 22, 2023NAFCILLIN 24GM IN NS 1200MLLack of sterility assuranceSentara Infusion Services · D-0310-2023Class IITerminatedFeb 22, 2023MYCAMINE 100MG IN NS 100MLLack of sterility assuranceSentara Infusion Services · D-0309-2023Class IITerminatedFeb 22, 2023MORPHINE SulfateLack of sterility assuranceSentara Infusion Services · D-0308-2023Class IITerminatedFeb 22, 2023MilrinoneLack of sterility assuranceSentara Infusion Services · D-0307-2023Class IITerminatedFeb 22, 2023METRONIDAZOLE 500MG 100MLLack of sterility assuranceSentara Infusion Services · D-0306-2023Class IITerminatedFeb 22, 2023Methylprednisolone 12MG IN NS 1.2ML SYRINGELack of sterility assuranceSentara Infusion Services · D-0305-2023Class IITerminatedFeb 22, 2023METHADONELack of sterility assuranceSentara Infusion Services · D-0304-2023Class IITerminatedFeb 22, 2023MEROPENEMLack of sterility assuranceSentara Infusion Services · D-0303-2023Class IITerminatedFeb 22, 2023LEVOTHYROXINE 25MCG IN NS 1.25ML SYRINGELack of sterility assuranceSentara Infusion Services · D-0302-2023